Breaking News

Symbio & Dow Group Merge with Proinnovera

Aims to generate efficiencies and accelerate clinical research.

Symbio LLC & Dow Development Laboratories LLC have merged with Proinnovera to form Symbio Proinnovera, a dermatology-focused clinical research organization. The Symbio & Dow Group has a full-service clinical trial CRO offering for dermatology, complemented by a business that is active in the preclinical formulation of topicals, providing services from preclinical formulation work to subsequent clinical trial execution. Proinnovera is a full-service CRO conducting clinical studies f...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters